We are looking for children 2–17 years old to join a CD clinical trial to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or moderate to severe ulcerative colitis (including associated symptoms such as rectal bleeding, unexplained weight loss, bloody stool, weight loss and/or eye pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to to join.
